Retatrutide is a triple hormone receptor agonist, acting on three receptors simultaneously: GLP-1 (glucagon-like peptide-1) reduces appetite and slows gastric emptying GIP (glucose-dependent insulinotropic polypeptide) enhances insulin secretion and may improve fat metabolism Glucagon receptor increases energy expenditure and promotes fat breakdown It is worth noting that glucagon receptor agonism can, in isolation, raise blood glucose levels
Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection
Semaglutide, a medication initially developed to treat type 2 diabetes and aid in weight loss, has also been found to impact cholesterol levels positively
Injecting into muscle rather than subcutaneous fat, which happens when the needle is too long or the injection angle is wrong for your body composition
But, GIP also has a unique trick it can stop the release of another hormone called glucagon when blood sugar is high, and it increases glucagon when its too low
Zero issues and no weird side effects